Ransomware doesn't need to breach your control room it needs to get close enough that you can't trust it hasn't. Learn how attackers cross the IT-OT boundary, why segmentation keeps failing, and what penetration testing finds before they do.

Nation-state actors treat pharma like critical infrastructure targeting formulation data, synthesis routes, and clinical IP with patience and precision. Learn why standard pen testing misses this threat and what adversary simulation reveals instead.